CTLA4 and neoplasm: Tumor cells secrete immunosuppressive cytokines (e.g., TGF-b, IL-10, VEGF), drive expression of inhibitory receptors and ligands (e.g., PD-L1/2, CTLA-4) and reduce tumor-specific MHC-I antigens.